Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 14/20 | 0.57 |
| ▸ | CTSB | P07858 | 6/20 | 0.57 |
| ▸ | CTSS | P25774 | 2/20 | 0.45 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.37 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | PYGL | P06737 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7694185 | 0.91 | CAPN1 (0.56) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7689896 | 0.89 | CAPN1 (0.75) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7696690 | 0.88 | CAPN1 (0.54) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7691158 | 0.88 | CAPN1 (0.54) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7697277 | 0.86 | CAPN1 (0.47) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7696610 | 0.86 | CAPN1 (0.58) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7690894 | 0.86 | CAPN1 (0.58) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7696093 | 0.86 | CAPN1 (0.54) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7690823 | 0.85 | CAPN1 (0.60) | CAPN1CTSBCTSSCTSKCTSL | |
| SCHEMBL7695427 | 0.85 | CAPN1 (0.56) | CAPN1CTSBCTSSCTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436925-B1 | BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES | ABBOTT LABORATORIES | 2002-08-20 | — | — | US | disclosed |